Note: GENEOS Therapeutics's revenues are gauged from an analysis of company filings.
GENEOS Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
November 17, 2020
Complete list of funding rounds and total amounts in the Company Report
GENEOS Therapeutics's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
GENEOS Therapeutics Revenue (Sales)
Cost of Goods Sold
Salaries and wages
Other Operating Expenses
Total Operating Expenses
EBIT (Earnings Before Interest and Taxes)
Trademark applications show the products and services that GENEOS Therapeutics is developing and marketing.
GENEOS Therapeutics's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
GT-EPIC Therapeutic pharmaceuticals for the personalized treatment of cancer and oncological conditions; pharmaceuticals, namely, immunotherapies for the personalized treatment of cancer and oncological conditions; immunotherapy products, namely, pharmaceutical products for the personalized treatment of cancer and oncological conditions
GENEOS THERAPEUTICS Research and development in the fields of pharmaceuticals, biopharmaceuticals and therapeutics; Research and development in the field of personalized medicine and its delivery to patients; Research and development in the field of oncology; Research and development of personalized cancer treatments; Medical and scientific research, namely, conducting clinical trials for others; Research and development of treatments for infectious diseases
Determine whether GENEOS Therapeutics grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof GENEOS Therapeutics is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of GENEOS Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as GENEOS Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to GENEOS Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as GENEOS Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.